These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 22581589)
1. The ultrasound-assisted extraction and identification of antifungal substances from B. amyloliquefaciens strain NJN-6 suppressing Fusarium oxysporum. Yuan J; Raza W; Huang Q; Shen Q J Basic Microbiol; 2012 Dec; 52(6):721-30. PubMed ID: 22581589 [TBL] [Abstract][Full Text] [Related]
2. Recovery of several cell pellet-associated antibiotics produced by Bacillus amyloliquefaciens NJN-6. Yuan J; Zhang F; Wu Y; Zhang J; Raza W; Shen Q; Huang Q Lett Appl Microbiol; 2014 Aug; 59(2):169-76. PubMed ID: 24702101 [TBL] [Abstract][Full Text] [Related]
3. Antifungal lipopeptides from Bacillus amyloliquefaciens strain BO7. Romano A; Vitullo D; Di Pietro A; Lima G; Lanzotti V J Nat Prod; 2011 Feb; 74(2):145-51. PubMed ID: 21235220 [TBL] [Abstract][Full Text] [Related]
4. Antifungal cyclic lipopeptides from Bacillus amyloliquefaciens strain BO5A. Romano A; Vitullo D; Senatore M; Lima G; Lanzotti V J Nat Prod; 2013 Nov; 76(11):2019-25. PubMed ID: 24164115 [TBL] [Abstract][Full Text] [Related]
5. Production of bacillomycin- and macrolactin-type antibiotics by Bacillus amyloliquefaciens NJN-6 for suppressing soilborne plant pathogens. Yuan J; Li B; Zhang N; Waseem R; Shen Q; Huang Q J Agric Food Chem; 2012 Mar; 60(12):2976-81. PubMed ID: 22385216 [TBL] [Abstract][Full Text] [Related]
6. Bacillus amyloliquefaciens Q-426 as a potential biocontrol agent against Fusarium oxysporum f. sp. spinaciae. Zhao P; Quan C; Wang Y; Wang J; Fan S J Basic Microbiol; 2014 May; 54(5):448-56. PubMed ID: 23553741 [TBL] [Abstract][Full Text] [Related]
7. Iturin A is the principal inhibitor in the biocontrol activity of Bacillus amyloliquefaciens PPCB004 against postharvest fungal pathogens. Arrebola E; Jacobs R; Korsten L J Appl Microbiol; 2010 Feb; 108(2):386-95. PubMed ID: 19674188 [TBL] [Abstract][Full Text] [Related]
8. Purification and Identification of Two Antifungal Cyclic Peptides Produced by Bacillus amyloliquefaciens L-H15. Han Y; Zhang B; Shen Q; You C; Yu Y; Li P; Shang Q Appl Biochem Biotechnol; 2015 Aug; 176(8):2202-12. PubMed ID: 26123083 [TBL] [Abstract][Full Text] [Related]
9. ESI LC-MS and MS/MS characterization of antifungal cyclic lipopeptides produced by Bacillus subtilis XF-1. Li XY; Mao ZC; Wang YH; Wu YX; He YQ; Long CL J Mol Microbiol Biotechnol; 2012; 22(2):83-93. PubMed ID: 22614917 [TBL] [Abstract][Full Text] [Related]
10. NMR spectroscopic and MS/MS spectrometric characterization of a new lipopeptide antibiotic bacillopeptin B1 produced by a marine sediment-derived Bacillus amyloliquefaciens SH-B74. Ma Z; Hu J; Wang X; Wang S J Antibiot (Tokyo); 2014 Feb; 67(2):175-8. PubMed ID: 24064466 [No Abstract] [Full Text] [Related]
11. Quantification of the antifungal lipopeptide iturin A by high performance liquid chromatography coupled with aqueous two-phase extraction. Yuan J; Raza W; Huang Q; Shen Q J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(26):2746-50. PubMed ID: 21872538 [TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry identification of antifungal lipopeptides from Bacillus sp. BCLRB2 against Rhizoctonia solani and Sclerotinia sclerotiorum. Elkahoui S; Djébali N; Karkouch I; Ibrahim AH; Kalai L; Bachkovel S; Tabbene O; Limam F Prikl Biokhim Mikrobiol; 2014; 50(2):184-8. PubMed ID: 25272736 [TBL] [Abstract][Full Text] [Related]
13. A Thermotolerant Marine Singh P; Xie J; Qi Y; Qin Q; Jin C; Wang B; Fang W Mar Drugs; 2021 Sep; 19(9):. PubMed ID: 34564178 [TBL] [Abstract][Full Text] [Related]
14. Production of biosurfactant lipopeptides Iturin A, fengycin and surfactin A from Bacillus subtilis CMB32 for control of Colletotrichum gloeosporioides. Kim PI; Ryu J; Kim YH; Chi YT J Microbiol Biotechnol; 2010 Jan; 20(1):138-45. PubMed ID: 20134245 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity and spectroscopic characterization of surfactin class of lipopeptides from Bacillus amyloliquefaciens SR1. Nanjundan J; Ramasamy R; Uthandi S; Ponnusamy M Microb Pathog; 2019 Mar; 128():374-380. PubMed ID: 30695712 [TBL] [Abstract][Full Text] [Related]
17. [Purification and identification of iturin A from Bacillus subtilis JA by electrospray ionization mass spectrometry]. Chen H; Yuan C; Cai K; Zheng Z; Yu Z Wei Sheng Wu Xue Bao; 2008 Jan; 48(1):116-20. PubMed ID: 18338587 [TBL] [Abstract][Full Text] [Related]
18. Antifungal activity of Bacillus amyloliquefaciens NJN-6 volatile compounds against Fusarium oxysporum f. sp. cubense. Yuan J; Raza W; Shen Q; Huang Q Appl Environ Microbiol; 2012 Aug; 78(16):5942-4. PubMed ID: 22685147 [TBL] [Abstract][Full Text] [Related]
19. Antagonistic Activities of Novel Peptides from Bacillus amyloliquefaciens PT14 against Fusarium solani and Fusarium oxysporum. Kim YG; Kang HK; Kwon KD; Seo CH; Lee HB; Park Y J Agric Food Chem; 2015 Dec; 63(48):10380-7. PubMed ID: 26496638 [TBL] [Abstract][Full Text] [Related]
20. A Novel Variant of Narrow-Spectrum Antifungal Bacterial Lipopeptides That Strongly Inhibit Ganoderma boninense. Pramudito TE; Agustina D; Nguyen TKN; Suwanto A Probiotics Antimicrob Proteins; 2018 Mar; 10(1):110-117. PubMed ID: 29101528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]